Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilocarpine PD in Healthy Subjects
NCT02447315Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- May 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pilocarpine in xerostomia (4 arms), sponsored by Astellas Pharma. Primary endpoints: Pharmacodynamic parameter salivary secretion, Area under the effect-time curve, saliva and 2 more. Started May 2015; status: completed.
02
Drugs
pilocarpine
03
Conditions
xerostomia
Beyond the preview
Go deeper on NCT02447315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447315.